Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Endocrinology
•
Male and Female Reproductive Disorders
•
General Endocrinology
When do you recommend the use of oral testosterone replacement over injectable testosterone?
Ahmad et al., PMID 36106278
Answer from: at Community Practice
Oral testosterone was approved by the FDA for men who have low testosterone levels due to specific medical conditions, such as genetic disorders like Klinefelter syndrome or pituitary conditions causing damage to the pituitary gland.
Sign in or Register to read more
23529
Related Questions
Does a patient with an endometrial ablation need progesterone if prescribed estradiol for menopausal HRT?
Do you recommend using anastrazole in men developing gynecomastia while on testosterone replacement treatment for hypogonadism depending on pre-treatment estradiol level?
Can clomiphene therapy cause low libido while increasing the testosterone level in men with low testosterone?
Do you recommend a trial of testosterone replacement therapy in male patients with symptoms consistent with hypogonadism, low total testosterone but normal free androgen index (FAI)?
Is there any evidence that spironolactone or finasteride therapy increase blood levels of testosterone?
When do you recommend using L-arginine stimulated copeptin testing to evaluate for central diabetes insipidus (AVP-deficiency)?
In obese men presenting with gynecomastia, elevated estrogens, and hypogonadism, what clinical factors would push you to obtain testicular and/or adrenal imaging to rule out an estrogen-producing tumor?
Should we recommend SGLT2i initiation at discharge to all patients hospitalized with acute myocardial infarction?
What is the typical timeline for remission of autoimmune hypoglycemia?
Should we be using body fat percentage instead of BMI for determining patients' risk of metabolic syndrome?